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Background: Chikungunya (CHIKV) is an arthropod-borne
virus belonging to the Alphavirus genus in the Togaviridae
family. Epidemic Chikungunya virus (CIKV) infections result
common limited to several countries of the tropical areas.
The only epidemic of CHIKV that aroused outside the trop-
ical areas was the small epidemic outbreak occurred in the
Emilia Romagna region, Italy, during summer of 2007. Local
transmission has been made possible by the enormous pop-
ulation of Aedes albopictus. On the basis of these facts,
a serological screening of chikungunya fever was initiated
by Centro Riferimento Regionale Emergenze Microbiologiche
(CRREM) of Bologna to determine the speciﬁc CHIKV IgG and
IgM titres in conﬁrmed CHIKV case.
Methods: Serum obtained from the 172 CHIKV infected
persons were collected and tested for the presence of CHIKV
antibodies. Speciﬁc antibodies titres were analyzed by an
indirect immunoﬂuorescence assay for the detection of anti-
CHIKV IgG and IgM by using a commercial EUROIMMUN assay.
Results: During the outbreak occurred in Emilia-Romagna
on 2007, all serum from laboratory conﬁrmed CHIKV infec-
tions were collected and tested as follows. Of these samples,
108 (62,8%) were CHIKV positive both in IgM and IgG, 27
(15,6%) were only IgM positive, 12 (6.9%) were IgG positive
only. In opposite, 25 (14,5%) were negative both for IgM and
IgG, but tested PCR positive. Moreover the 71,4% of the IgM
positive samples had a titre comprised between 1/100 and
1/1600. In addition the 85,8% of the IgG positive samples
had a titre ranging from 1/100 to 1/6400.
Conclusion: Here we report the ﬁrst sero-prevalence
study for speciﬁc CHIKV-antibodies in a population outside
the tropical geographic areas. In addition, this study was
performed on all the autochthonous CHIKV infected persons.
The results obtained clearly demonstrated the high level of
antibody response to CHIKV in the acute phase, or immedi-
ately after, infection. Studies are presently on going in order
to deﬁne the persistence of CHIKV speciﬁc antibodies.
doi:10.1016/j.ijid.2010.02.1951
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Background: West Nile virus (WNV) is a member of the ﬂa-
ivirus family and is transmitted in natural cycles between
irds and mosquitoes, particularly Culex spp. Human and
orses are susceptible but dead-end hosts. Firstly identi-
ed in tropical Africa, WNV infection has been evidenced in
orthern Africa, Israel, India and Australia. WNV spread in
merica since 1999 and has been the cause of outbreaks
nd sporadic cases in central eastern and Mediterranean
urope for more than 45 years. Of people infected with
osquito-borne WNV, 80% develop asymptomatic infections,
0% develop symptomatic infections and <1% develop severe
euro-invasive disease. The ﬁrst human cases of neuro-
nvasive WNV infection was identiﬁed in 2008 near Ferrara
rovince where had been identiﬁed several WNV-positive
orses and birds. After this ﬁrst case of WNV infection in
milia-Romagna, a sero-epidemiological survey was started
o ascertain the sero-prevalence of speciﬁc antibodies in the
lood donor population and the relative risk in population.
Methods: Serum obtained from 10.000 blood donors
esident in Ferrara province were collected between
eptember 2008 to April 2009, and tested for speciﬁc WNV.
irus-speciﬁc IgG were detected in serum specimens by
nzyme-linked immunosorbent assay (ELISA). To conﬁrm
esults of positive IgG samples and to determine the effec-
ively titers in the serum, an Immuno Fluorescent assay (IFA)
as performed.
Results: Between a period of 8 months, since autumn
008, 10.000 serum obtained by blood donors in Ferrara
rovince were collected and tested as described in previ-
usly. 70 of the 10.000 serum analyzed resulted positive in
gG. This data showing an incidence of 0.7% in a blood donors
opulation.
Conclusion: After the outbreak of WNV infections in Italy
uring the 2008, a sero-prevalence study was performed to
etermine the WNV mosquitoes-related infections in a blood
onors in Italy. We report the ﬁrst study of human sero-
revalence in Europe involving a high number of persons.
he ﬁrst data of the study show an incidence of 0,7% and
uggest the large diffusion of WNV in the area studied. In
ddition, the high incidence prospect a necessary surveil-
ance in blood and organ donors, performed by NAAT in this
art of Italy.
oi:10.1016/j.ijid.2010.02.1952
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